Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
9(25%)
Results Posted
10%(1 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_2
4
11%
Ph early_phase_1
1
3%
Ph not_applicable
12
33%

Phase Distribution

1

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
1(5.9%)
Phase 2Efficacy & side effects
4(23.5%)
N/ANon-phased studies
12(70.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

9

trials recruiting

Total Trials

36

all time

Status Distribution
Active(14)
Completed(10)
Terminated(1)
Other(11)

Detailed Status

unknown11
Completed10
Recruiting8
Not yet recruiting5
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
36
Active
9
Success Rate
90.9%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (5.9%)
Phase 24 (23.5%)
N/A12 (70.6%)

Trials by Status

recruiting822%
unknown1131%
completed1028%
terminated13%
active_not_recruiting13%
not_yet_recruiting514%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT04239573Not Applicable

Comparing Two Methods to Follow Patients With Pancreatic Cysts

Recruiting
NCT06440174

Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

Recruiting
NCT07529483Phase 2

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms

Not Yet Recruiting
NCT06078709Phase 2

Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma

Recruiting
NCT07407296

Multimodal Endoscopic Ultrasound in the Evaluation of Indeterminate Upper Gastrointestinal Wall Thickening

Not Yet Recruiting
NCT06381154Phase 2

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Recruiting
NCT02372929

Relationship Between Endoscopic Ultrasound Staging and Degree of Stricture in Esophageal Cancer

Completed
NCT07106411

CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study

Not Yet Recruiting
NCT03033225Phase 2

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

Completed
NCT06717906Not Applicable

Comparing TRIple Rectal Ultrasound Imaging Technology in Ulcerative Colitis

Completed
NCT06122896Early Phase 1

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Recruiting
NCT05058846

Pilot Study of Pancreatic Cancer Screening

Recruiting
NCT02206360

Pancreatic Cancer Early Detection Program

Active Not Recruiting
NCT04851106

Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma.

Recruiting
NCT06363682

Interventional Reference Levels (IRL) in Digestive Endoscopy

Not Yet Recruiting
NCT05187312

Registry for Advanced Endoscopy

Recruiting
NCT05621824

A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS

Not Yet Recruiting
NCT05762653

Morphological Pancreatic Features in Diabetes Mellitus Type 2

Unknown
NCT04876235Not Applicable

A Comparison Between Lumen-apposing Metal Stent and Double-pigtail Plastic Stents for Treatment of Walled-off Necrosis

Completed
NCT05674123Not Applicable

Evaluating the Safety and Effectiveness of the Flex Robotic System for the Surgical Removal of Colorectal Lesions

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
36